Artivion, Inc., previously known as Avinger Inc., is a leading, publicly traded company specializing in the medical device industry. The company operates under the ticker symbol "AORT" on NASDAQ. Headquartered in Redwood City, California, this innovative corporation strives to design, develop, and manufacture pioneering image-guided, catheter-based systems that are poised to significantly enhance treatment for patients with peripheral artery disease (PAD).
Artivion, Inc. is highly renowned for its dedication to break new grounds in the field of medical technology through its novel Lumivascular platform. The Lumivascular approach is the very first-ever technology which enables physicians to view the inside of arteries in real time during the treatment procedure. Leveraging optical coherence tomography (OCT), an advanced imaging technique notably used in ophthalmology, this allows doctors to treat PAD with far greater precision and safety, thus contributing to more effective patient care and improved clinical outcomes.
The company’s suite of products, including the Lightbox imaging console, Ocelot family of chronic total occlusion (CTO) catheters, and Pantheris family of atherectomy devices, are widely recognized for taking the initiative to equip physicians with the most advanced tools for treating patients with PAD. Moreover, the Pantheris Lumivascular atherectomy system holds the distinction of being the first and only image-guided atherectomy device for PAD treatment.
Artivion, Inc. is driven by a strong commitment to clinical research and education. The company continuously seeks ways to produce state-of-art medical devices while also staying at the fore of evidence-based medicine. Its name change from Avinger to Artivion, effected in 2021, reflects a fresh direction in the company's strategy with novel devices and broader innovation beyond vascular interventions.
Artivion, Inc. operates with an exceptional team of experienced professionals under the leadership of highly proficient executives. The company cultivates a culture of determination and innovation with the ultimate objective to enhance standards of care and offer superior solutions for peripheral arterial disease management to physicians worldwide.